92N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992
CH 1 Health Industry Distributers Association Vol#: 6
94P-0036 Req labeling of trans fatty acid & prohibit deceptive claims
C 2184 Fred R Selarge Vol#: 64
EMC 484 William Welborn Vol#: 64
98P-0203 Eliminate Forced Molting of Laying Birds
C 1955 Allyson B Wright Vol#: 47
99D-5435 Draft Guidance for Industry on Photosafety Testing
99F-2673 Irradiation in the Production, Processing & Handling of Food
BKG 1 BACKGROUND MATERIAL Vol#: 1
NFR 1 Vol#: 1
99P-2630 Establish a Daily Value for "added sugars"
C 566 Lyn Verthein Vol#: 26
C 567 Eleanore M Carberry Vol#: 26
C 568 Bonnie L Smith Vol#: 26
EMC 407 Paige Lawlis-Dixon Vol#: 26
EMC 408 Karen Sanchirico Vol#: 26
EMC 409 Alan & Kay Robinson Vol#: 26
EMC 410 Deborah Thom Vol#: 26
EMC 411 Mark Goldman Vol#: 26
EMC 412 Jack Thach Vol#: 26
EMC 413 No signature (CHS9) Vol#: 26
99P-5215 Provisions of Title 21 of the Code of Federal Regulations
LET 3 Assn of American Physicians & Surgeon et Vol#: 1
00D-0186 M4 Common Technical Document;InterNatl Confern on Harmonisat
EMC 1 Ministry of Health & Welfare, JPMA Vol#: 2
00D-1418 Q7A ICH Good Manufacturing Practice Guide for Active Pharmac
ECT 6 TAKEDA CHEMICAL INDUSTRIES, LTD. Vol#: 2
ECT 7 Yamanouchi Pharmaceutical Co., Ltd. Vol#: 2
ECT 8 Sumitomo Pharmaceuticals Co., Ltd. Vol#: 2
ECT 9 Fujisawa Pharmaceutical Co.Ltd. Vol#: 2
ECT 10 KYOWA HAKKO KOGYO CO.,LTD. Vol#: 2
ECT 11 Sankyo Company, Ltd. Vol#: 2
ECT 12 TANABE SEIYAKU CO.,LTD. Vol#: 2
ECT 13 Taisho Pharmaceutical Co., Ltd. Vol#: 2
ECT 14 Eisai Co.,LTD.Kashima Plant Vol#: 2
ECT 15 Suntory Bio-Pharma Tech Center Vol#: 2
00N-1200 Dietary Supplements Containing Ephedrine Alkaloids
EC 9 CA Depart, of Hlth Services, Food and Dr Vol#: 68
EC 10 Association of Food and Drug Officials Vol#: 68
EC 11 Texas Department of Health Vol#: 68
00N-1364 Prescription Drug User Fee Act (PDUFA) Public Meeting
EC 22 American Society of Health-System Pharma Vol#: 3
00N-1409 Revision of the Identification of the Ionotophoresis
M 1 HFZ-1 Extend Comment Period to 12/19/00 Vol#: 1
00N-1449 Changes to an Approved NDA or ANDA;Agency Information Collec
C 1 Pharmacia Corporation Vol#: 1
00N-1460 Salmonella Enteritidis Research Public Meeting
00N-1503 Agency Information Collection:Orphan Drugs
EC 2 no Vol#: 1
00N-1511 Petition for Administrative Reconsideration of Action
EC 1 Number Not Used Vol#: 1
00P-1499 Remove alosetron (Lotronex) from the market
SUP 1 Public Citizen Health Research Group Vol#: 1
00P-1550 Approve ANDA for Cefuroxime Axetil Products